양자-AI 하이브리드 모델, 신약 설계에서 고전 컴퓨터를 제쳤다
DTU와 Orca Computing의 하이브리드 모델이 고전적 방법보다 더 많은 성공적인 펩타이드를 생성해, 양자 기술이 희귀질환 신약 개발을 개선할 수 있음을 입증했습니다.
a team from the technical university of denmark used a printer-sized quantum computer from orca computing to boost a generative ai model for predicting proteins, resulting in more successful peptides than classical counterparts. the hybrid approach excelled specifically where training data was sparse, addressing a critical gap in developing therapies for non-western populations. while current quantum hardware lacks the power for full-scale antibody design, this experiment provides a concrete near-term commercial application for the technology.